Abstract
In recent years, metagenome-wide association studies have revealed potential relationships between intestinal microbiomes and the pathogenesis of type 2 diabetes mellitus (T2DM). However, considering the increase in volume of gene catalogues and algorithms, an updated analysis would be expected to confirm previous discoveries and provide new knowledge. We therefore constructed new profiles after mapping the recent catalogue of reference genes in the human gut microbiome to reanalyze samples from T2DM cases and controls in the Chinese population. We identified different compositions between Chinese controls and T2DM patients at the species and genus levels, especially in the case of butyrate-producing bacteria, Haemophilus, and Lactobacillus. An effective metagenomic linkage group random forest model was built to differentiate controls from T2DM cases in different cohorts. Functional markers from the Kyoto Encyclopedia of Genes and Genomes database were identified using new annotations. We also report 16 virulence factor markers and 22 antibiotic resistance markers associated with T2DM.
This is a preview of subscription content, log in via an institution to check access.
References
Brook I (1995) Clostridial infection in children. J Med Microbiol 42(2):78–82
Cani PD, Amar J, Iglesias MA, Poggi M, Knauf C, Bastelica D et al (2007) Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56(7):1761–1772
Chen L, Yang J, Yu J, Yao Z, Sun L, Shen Y et al (2005) Vfdb: a reference database for bacterial virulence factors. Nucleic Acids Res 333(Database issue):25–28
Chen L, Xiong Z, Sun L, Yang J, Jin Q (2011) Vfdb 2012 update: toward the genetic diversity and molecular evolution of bacterial virulence factors. Nucleic Acids Res 40(Database issue):D641–D645
Dan K, Costello EK, Knight R (2011) Supervised classification of human microbiota. FEMS Microbiol Rev 35(2):343–359
Feng Q, Liang S, Jia H, Stadlmayr A, Tang L, Lan Z et al (2015) Gut microbiome development along the colorectal adenoma-carcinoma sequence. Nat Commun 6:6528
Forslund K, Hildebrand F, Nielsen T, Falony G, Le CE, Sunagawa S et al (2015) Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota. Nature 528(7581):262–266
Karjalainen KM, Knuuttila ML, Käär ML (1996) Salivary factors in children and adolescents with insulin-dependent diabetes mellitus. Pediatr Dent 18(4):306–311
Karlsson FH, Fåk F, Nookaew I, Tremaroli V, Fagerberg B, Petranovic D et al (2012) Symptomatic atherosclerosis is associated with an altered gut metagenome. Nat Commun 3(4):1245
Karlsson FH, Tremaroli V, Nookaew I, Bergström G, Behre CJ, Fagerberg B, Nielsen J, Bäckhed F (2013) Gut metagenome in european women with normal, impaired and diabetic glucose control. Nature 498(7452):99–103
Kultima JR, Sunagawa S, Li J, Chen W, Chen H, Mende DR et al (2012) Mocat: a metagenomics assembly and gene prediction toolkit. PLoS ONE 7(10):e47656
Kverka M, Zakostelska Z, Klimesova K, Sokol D, Hudcovic T, Hrncir T et al (2011) Oral administration of parabacteroides distasonis, antigens attenuates experimental murine colitis through modulation of immunity and microbiota composition. Clin Exp Immunol 163(2):250–259
Li R, Yu C, Li Y, Lam TW, Yiu SM, Kristiansen K et al (2009) Soap2: an improved ultrafast tool for short read alignment. Bioinformatics 25(15):1966–1967
Li J, Jia H, Cai X, Zhong H, Feng Q, Sunagawa S et al (2014) An integrated catalog of reference genes in the human gut microbiome. Nat Biotechnol 32(8):834–841
Liu B, Pop M (2009) Ardb—antibiotic resistance genes database. Nucleic Acids Res 37(Database issue):443–447
Markowitz VM, Chen IM, Palaniappan K, Chu K, Szeto E, Grechkin Y et al (2012) Img: the integrated microbial genomes database and comparative analysis system. Nucleic Acids Res 40(Database issue):D122
Mcclean KL, Sheehan GJ, Harding GK (1994) Intraabdominal infection: a review. Clin Infect Dis 19(19):100–116
Mercadolubo R, Mccormick BA (2010) The interaction of gut microbes with host abc transporters. Gut Microbes 1(5):301–306
Miquel S, Martín R, Rossi O, Bermúdez-Humarán LG, Chatel JM, Sokol H et al (2013) Faecalibacterium prausnitzii, and human intestinal health. Curr Opin Microbiol 16(3):255–261
Newsholme P, Brennan L, Bender K (2006) Amino acid metabolism, Î2-cell function, and diabetes. Diabetes 55(Supplement 2):S39–S47
Noble D, Mathur R, Dent T, Meads C, Greenhalgh T (2011) Risk models and scores for type 2 diabetes: systematic review. BMJ 343(6):d7163
Norman JM, Handley SA, Virgin HW (2014) Kingdom-agnostic metagenomics and the importance of complete characterization of enteric microbial communities. Gastroenterology 146(6):1459–1469
Oliveira AP, Patil KR, Nielsen J (2008) Architecture of transcriptional regulatory circuits is knitted over the topology of bio-molecular interaction networks. BMC Syst Biol 2(3):462–468
Patil KR, Nielsen J (2005) Uncovering transcriptional regulation of metabolism by using metabolic network topology. Proc Natl Acad Sci USA 102(8):2685–2689
Qin J, Li Y, Cai Z, Li S, Zhu J, Zhang F et al (2012) A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 490(7418):55–60
Sameer Elsayed KZ (2004) Bacteremia caused by clostridium symbiosum. J Clin Microbiol 42(9):4390–4392
Schutze GE, Willoughby RE, Diseases COI, Pediatrics AAO (2013) Clostridium difficile infection in infants and children. Pediatrics 131(1):196–200
Scott LJ, Mohlke KL, Bonnycastle LL, Willer CJ, Li Y, Duren WL et al (2007) A genome-wide association study of type 2 diabetes in finns detects multiple susceptibility variants. Science 316(5829):1341–1345
Sokol H, Pigneur B, Watterlot L, Lakhdari O, Bermúdezhumarán LG, Gratadoux JJ et al (2008) Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of crohn disease patients. Proc Natl Acad Sci USA 105(43):16731–16736
Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI (2006) An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444(7122):1027–1031
Virgin HW (2014) The virome in mammalian physiology and disease. Cell 157(1):142–150
Vrieze A, Nood EV, Holleman F, Salojärvi J, Kootte RS, Bartelsman JFWM et al (2012) Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology 143(4):913–916(e7)
Yu J, Qiang F, Wong SH, Zhang D, Qiao YL, Qin Y et al (2015) Metagenomic analysis of faecal microbiome as a tool towards targeted non-invasive biomarkers for colorectal cancer. Gut 33(5):905–912
Zhang X, Zhang D, Jia H, Feng Q, Wang D, Liang D et al (2015) The oral and gut microbiomes are perturbed in rheumatoid arthritis and partly normalized after treatment. Nat Med 21(8):895–905
Acknowledgements
This work was carried out using computing resources at BGI Shenzhen. We thank colleagues in the IT department of BGI Shenzhen for their help.
Author information
Authors and Affiliations
Corresponding author
Additional information
Xiaokai Wang and Xiaoqiang Xu have contributed equally to this work.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Wang, X., Xu, X. & Xia, Y. Further analysis reveals new gut microbiome markers of type 2 diabetes mellitus. Antonie van Leeuwenhoek 110, 445–453 (2017). https://doi.org/10.1007/s10482-016-0805-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10482-016-0805-3